LTF and acute lymphoblastic leukemia: On the other hand, a concomitant modification in these parameters was noticed proceeding cisplatin, TiNPs-cisplatin and lactoferrin-cisplatin, doxorubicin, TiNPs-doxorubicin, lactoferrin–doxorubicin and neupogen treatment with the lactoferrin-loaded drugs elucidating the highest significant impact highlighting the impact of these gene mutations in T-ALL.